Effectiveness of liposomal and ferrous iron in the treatment of iron deficiency

Phase 4

• Conditions: Condition 1: Iron deficiency. Condition 2: Iron deficiency anemia.; Iron deficiency; Other iron deficiency anemias; E61.1; D50.8

• Registration Number: IRCT20151020024625N17
• Lead Sponsor: Semnan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with iron deficiency and iron deficiency anemia

Exclusion Criteria

A history for use of iron supplements
Hemoglobinopathy
Severe anemia or anemia due to other causes
Asthma
Malignancy
Active infection
Renal dysfunction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum Iron. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Biochemical test.;Ferritin. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Biochemical test.;Total Iron-Binding Capacity. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Biochemical test.;Hemoglubin. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Hematological test.;Hematocrit. Timepoint: Before and 4 and 12 weeks after intervention. Method of measurement: Hematological test.